Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic

RDF 

 
This item is provided by the institution :
Hellenic Gastroenterologiki Company
Repository :
Annals of Gastroenterology
see item page
in the web site of the repository *
share



Semantic enrichment/homogenization by EKT
Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic (EN)

Allard, Johane
Mouzaki, Marialena

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Nonalcoholicsteatohepatitis (NASH) reflects severe liver disease within the NAFLD spectrumand can progress to end-stage liver disease. Within this manuscript we review the availableevidence for the treatment of NASH as well as the newer therapeutic agents that are currentlybeing investigated.Keywords NASH, fatty liver, treatment, vitamin E, pioglitazoneAnn Gastroenterol 2012; 25 (2): 207-217 (EN)

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Gastroenterologiki Company (EN)

2012-06-26


Annals of Gastroenterology (EN)

Annals of Gastroenterology; Volume 25, No 3 (2012); 207 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)